nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS1—kidney cancer	0.449	0.636	CbGaD
Tenoxicam—PTGS2—kidney cancer	0.257	0.364	CbGaD
Tenoxicam—SLC22A8—nephron—kidney cancer	0.00827	0.236	CbGeAlD
Tenoxicam—SLC22A8—urine—kidney cancer	0.00663	0.19	CbGeAlD
Tenoxicam—CYP2C9—Capecitabine—kidney cancer	0.00605	0.458	CbGbCtD
Tenoxicam—PTGS2—nephron—kidney cancer	0.00469	0.134	CbGeAlD
Tenoxicam—CYP2C9—urine—kidney cancer	0.00431	0.123	CbGeAlD
Tenoxicam—CYP2C9—Paclitaxel—kidney cancer	0.00379	0.287	CbGbCtD
Tenoxicam—CYP2C9—Sorafenib—kidney cancer	0.00336	0.255	CbGbCtD
Tenoxicam—Lornoxicam—PTGS1—kidney cancer	0.00182	0.291	CrCbGaD
Tenoxicam—SLC22A8—nephron tubule—kidney cancer	0.00179	0.051	CbGeAlD
Tenoxicam—SLC22A8—renal system—kidney cancer	0.00162	0.0464	CbGeAlD
Tenoxicam—SLC22A8—kidney—kidney cancer	0.00157	0.0449	CbGeAlD
Tenoxicam—SLC22A8—cortex of kidney—kidney cancer	0.00153	0.0437	CbGeAlD
Tenoxicam—Meloxicam—PTGS1—kidney cancer	0.00116	0.185	CrCbGaD
Tenoxicam—Lornoxicam—PTGS2—kidney cancer	0.00104	0.166	CrCbGaD
Tenoxicam—Piroxicam—PTGS1—kidney cancer	0.001	0.16	CrCbGaD
Tenoxicam—PTGS1—renal system—kidney cancer	0.000963	0.0275	CbGeAlD
Tenoxicam—PTGS1—kidney—kidney cancer	0.000931	0.0266	CbGeAlD
Tenoxicam—PTGS2—renal system—kidney cancer	0.00092	0.0263	CbGeAlD
Tenoxicam—PTGS2—kidney—kidney cancer	0.00089	0.0254	CbGeAlD
Tenoxicam—PTGS1—cardiac atrium—kidney cancer	0.000862	0.0247	CbGeAlD
Tenoxicam—Meloxicam—PTGS2—kidney cancer	0.000661	0.106	CrCbGaD
Tenoxicam—Piroxicam—PTGS2—kidney cancer	0.000573	0.0916	CrCbGaD
Tenoxicam—Leukopenia—Vincristine—kidney cancer	0.000305	0.00144	CcSEcCtD
Tenoxicam—Urethral disorder—Paclitaxel—kidney cancer	0.000305	0.00144	CcSEcCtD
Tenoxicam—Thrombocytopenia—Dactinomycin—kidney cancer	0.000305	0.00144	CcSEcCtD
Tenoxicam—Dyspnoea—Sorafenib—kidney cancer	0.000305	0.00144	CcSEcCtD
Tenoxicam—Dyspepsia—Sorafenib—kidney cancer	0.000301	0.00142	CcSEcCtD
Tenoxicam—Visual impairment—Paclitaxel—kidney cancer	0.0003	0.00141	CcSEcCtD
Tenoxicam—Anaemia—Gemcitabine—kidney cancer	0.000299	0.00141	CcSEcCtD
Tenoxicam—Decreased appetite—Sorafenib—kidney cancer	0.000297	0.0014	CcSEcCtD
Tenoxicam—Anorexia—Dactinomycin—kidney cancer	0.000297	0.0014	CcSEcCtD
Tenoxicam—Nausea—Pazopanib—kidney cancer	0.000296	0.0014	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000295	0.00139	CcSEcCtD
Tenoxicam—Fatigue—Sorafenib—kidney cancer	0.000295	0.00139	CcSEcCtD
Tenoxicam—Erythema multiforme—Paclitaxel—kidney cancer	0.000294	0.00139	CcSEcCtD
Tenoxicam—Dyspnoea—Sunitinib—kidney cancer	0.000293	0.00138	CcSEcCtD
Tenoxicam—Constipation—Sorafenib—kidney cancer	0.000292	0.00138	CcSEcCtD
Tenoxicam—Hypersensitivity—Vinblastine—kidney cancer	0.000291	0.00137	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Capecitabine—kidney cancer	0.000291	0.00137	CcSEcCtD
Tenoxicam—Eye disorder—Paclitaxel—kidney cancer	0.000291	0.00137	CcSEcCtD
Tenoxicam—Hypersensitivity—Everolimus—kidney cancer	0.00029	0.00137	CcSEcCtD
Tenoxicam—Dyspepsia—Sunitinib—kidney cancer	0.000289	0.00137	CcSEcCtD
Tenoxicam—Leukopenia—Gemcitabine—kidney cancer	0.000289	0.00137	CcSEcCtD
Tenoxicam—Cardiac disorder—Paclitaxel—kidney cancer	0.000289	0.00136	CcSEcCtD
Tenoxicam—Decreased appetite—Sunitinib—kidney cancer	0.000286	0.00135	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000284	0.00134	CcSEcCtD
Tenoxicam—Asthenia—Vinblastine—kidney cancer	0.000284	0.00134	CcSEcCtD
Tenoxicam—Fatigue—Sunitinib—kidney cancer	0.000284	0.00134	CcSEcCtD
Tenoxicam—Asthenia—Everolimus—kidney cancer	0.000282	0.00133	CcSEcCtD
Tenoxicam—Angiopathy—Paclitaxel—kidney cancer	0.000282	0.00133	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000282	0.00133	CcSEcCtD
Tenoxicam—Constipation—Sunitinib—kidney cancer	0.000281	0.00133	CcSEcCtD
Tenoxicam—Immune system disorder—Paclitaxel—kidney cancer	0.000281	0.00133	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Capecitabine—kidney cancer	0.00028	0.00132	CcSEcCtD
Tenoxicam—Myocardial infarction—Capecitabine—kidney cancer	0.000279	0.00132	CcSEcCtD
Tenoxicam—Pruritus—Everolimus—kidney cancer	0.000279	0.00132	CcSEcCtD
Tenoxicam—Anaphylactic shock—Vincristine—kidney cancer	0.000278	0.00131	CcSEcCtD
Tenoxicam—Oedema—Vincristine—kidney cancer	0.000278	0.00131	CcSEcCtD
Tenoxicam—Stomatitis—Capecitabine—kidney cancer	0.000277	0.00131	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000273	0.00129	CcSEcCtD
Tenoxicam—Nervous system disorder—Vincristine—kidney cancer	0.000273	0.00129	CcSEcCtD
Tenoxicam—Asthenia—Erlotinib—kidney cancer	0.000273	0.00129	CcSEcCtD
Tenoxicam—Mental disorder—Paclitaxel—kidney cancer	0.000272	0.00129	CcSEcCtD
Tenoxicam—Thrombocytopenia—Vincristine—kidney cancer	0.000272	0.00129	CcSEcCtD
Tenoxicam—Urticaria—Sorafenib—kidney cancer	0.000271	0.00128	CcSEcCtD
Tenoxicam—Erythema—Paclitaxel—kidney cancer	0.000271	0.00128	CcSEcCtD
Tenoxicam—Malnutrition—Paclitaxel—kidney cancer	0.000271	0.00128	CcSEcCtD
Tenoxicam—Decreased appetite—Dactinomycin—kidney cancer	0.000271	0.00128	CcSEcCtD
Tenoxicam—Diarrhoea—Vinblastine—kidney cancer	0.00027	0.00128	CcSEcCtD
Tenoxicam—Diarrhoea—Everolimus—kidney cancer	0.000269	0.00127	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Capecitabine—kidney cancer	0.000269	0.00127	CcSEcCtD
Tenoxicam—Pruritus—Erlotinib—kidney cancer	0.000269	0.00127	CcSEcCtD
Tenoxicam—Fatigue—Dactinomycin—kidney cancer	0.000268	0.00127	CcSEcCtD
Tenoxicam—Agranulocytosis—Capecitabine—kidney cancer	0.000265	0.00125	CcSEcCtD
Tenoxicam—Anorexia—Vincristine—kidney cancer	0.000265	0.00125	CcSEcCtD
Tenoxicam—Anaphylactic shock—Gemcitabine—kidney cancer	0.000264	0.00125	CcSEcCtD
Tenoxicam—Oedema—Gemcitabine—kidney cancer	0.000264	0.00125	CcSEcCtD
Tenoxicam—Dizziness—Vinblastine—kidney cancer	0.000261	0.00123	CcSEcCtD
Tenoxicam—Dizziness—Everolimus—kidney cancer	0.00026	0.00123	CcSEcCtD
Tenoxicam—Diarrhoea—Erlotinib—kidney cancer	0.00026	0.00123	CcSEcCtD
Tenoxicam—Nervous system disorder—Gemcitabine—kidney cancer	0.000259	0.00122	CcSEcCtD
Tenoxicam—Thrombocytopenia—Gemcitabine—kidney cancer	0.000258	0.00122	CcSEcCtD
Tenoxicam—Skin disorder—Gemcitabine—kidney cancer	0.000256	0.00121	CcSEcCtD
Tenoxicam—Hepatitis—Capecitabine—kidney cancer	0.000255	0.0012	CcSEcCtD
Tenoxicam—Urinary tract disorder—Capecitabine—kidney cancer	0.000252	0.00119	CcSEcCtD
Tenoxicam—Hypersensitivity—Sorafenib—kidney cancer	0.000252	0.00119	CcSEcCtD
Tenoxicam—Anorexia—Gemcitabine—kidney cancer	0.000252	0.00119	CcSEcCtD
Tenoxicam—Vomiting—Vinblastine—kidney cancer	0.000251	0.00119	CcSEcCtD
Tenoxicam—Dizziness—Erlotinib—kidney cancer	0.000251	0.00119	CcSEcCtD
Tenoxicam—Vomiting—Everolimus—kidney cancer	0.00025	0.00118	CcSEcCtD
Tenoxicam—Anaemia—Paclitaxel—kidney cancer	0.00025	0.00118	CcSEcCtD
Tenoxicam—Urethral disorder—Capecitabine—kidney cancer	0.00025	0.00118	CcSEcCtD
Tenoxicam—Rash—Everolimus—kidney cancer	0.000248	0.00117	CcSEcCtD
Tenoxicam—Dermatitis—Everolimus—kidney cancer	0.000248	0.00117	CcSEcCtD
Tenoxicam—Headache—Vinblastine—kidney cancer	0.000248	0.00117	CcSEcCtD
Tenoxicam—Angioedema—Paclitaxel—kidney cancer	0.000247	0.00117	CcSEcCtD
Tenoxicam—Headache—Everolimus—kidney cancer	0.000247	0.00116	CcSEcCtD
Tenoxicam—Visual impairment—Capecitabine—kidney cancer	0.000246	0.00116	CcSEcCtD
Tenoxicam—Asthenia—Sorafenib—kidney cancer	0.000245	0.00116	CcSEcCtD
Tenoxicam—Cardiac failure—Doxorubicin—kidney cancer	0.000244	0.00115	CcSEcCtD
Tenoxicam—Vertigo—Paclitaxel—kidney cancer	0.000243	0.00115	CcSEcCtD
Tenoxicam—Leukopenia—Paclitaxel—kidney cancer	0.000242	0.00114	CcSEcCtD
Tenoxicam—Hypersensitivity—Sunitinib—kidney cancer	0.000242	0.00114	CcSEcCtD
Tenoxicam—Decreased appetite—Vincristine—kidney cancer	0.000242	0.00114	CcSEcCtD
Tenoxicam—Pruritus—Sorafenib—kidney cancer	0.000242	0.00114	CcSEcCtD
Tenoxicam—Vomiting—Erlotinib—kidney cancer	0.000242	0.00114	CcSEcCtD
Tenoxicam—Erythema multiforme—Capecitabine—kidney cancer	0.000241	0.00114	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Vincristine—kidney cancer	0.00024	0.00113	CcSEcCtD
Tenoxicam—Fatigue—Vincristine—kidney cancer	0.00024	0.00113	CcSEcCtD
Tenoxicam—Rash—Erlotinib—kidney cancer	0.00024	0.00113	CcSEcCtD
Tenoxicam—Dermatitis—Erlotinib—kidney cancer	0.000239	0.00113	CcSEcCtD
Tenoxicam—Palpitations—Paclitaxel—kidney cancer	0.000239	0.00113	CcSEcCtD
Tenoxicam—Eye disorder—Capecitabine—kidney cancer	0.000238	0.00113	CcSEcCtD
Tenoxicam—Headache—Erlotinib—kidney cancer	0.000238	0.00112	CcSEcCtD
Tenoxicam—Constipation—Vincristine—kidney cancer	0.000238	0.00112	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000238	0.00112	CcSEcCtD
Tenoxicam—Cardiac disorder—Capecitabine—kidney cancer	0.000237	0.00112	CcSEcCtD
Tenoxicam—Asthenia—Sunitinib—kidney cancer	0.000236	0.00111	CcSEcCtD
Tenoxicam—Dyspnoea—Gemcitabine—kidney cancer	0.000235	0.00111	CcSEcCtD
Tenoxicam—Nausea—Vinblastine—kidney cancer	0.000235	0.00111	CcSEcCtD
Tenoxicam—Nausea—Everolimus—kidney cancer	0.000234	0.0011	CcSEcCtD
Tenoxicam—Diarrhoea—Sorafenib—kidney cancer	0.000234	0.0011	CcSEcCtD
Tenoxicam—Pruritus—Sunitinib—kidney cancer	0.000233	0.0011	CcSEcCtD
Tenoxicam—Angiopathy—Capecitabine—kidney cancer	0.000232	0.00109	CcSEcCtD
Tenoxicam—Immune system disorder—Capecitabine—kidney cancer	0.00023	0.00109	CcSEcCtD
Tenoxicam—Decreased appetite—Gemcitabine—kidney cancer	0.000229	0.00108	CcSEcCtD
Tenoxicam—Hypersensitivity—Dactinomycin—kidney cancer	0.000229	0.00108	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000229	0.00108	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000228	0.00108	CcSEcCtD
Tenoxicam—Fatigue—Gemcitabine—kidney cancer	0.000227	0.00107	CcSEcCtD
Tenoxicam—Dizziness—Sorafenib—kidney cancer	0.000226	0.00107	CcSEcCtD
Tenoxicam—Constipation—Gemcitabine—kidney cancer	0.000226	0.00107	CcSEcCtD
Tenoxicam—Nausea—Erlotinib—kidney cancer	0.000226	0.00107	CcSEcCtD
Tenoxicam—Dry mouth—Paclitaxel—kidney cancer	0.000225	0.00106	CcSEcCtD
Tenoxicam—Diarrhoea—Sunitinib—kidney cancer	0.000225	0.00106	CcSEcCtD
Tenoxicam—Mental disorder—Capecitabine—kidney cancer	0.000224	0.00106	CcSEcCtD
Tenoxicam—Asthenia—Dactinomycin—kidney cancer	0.000223	0.00105	CcSEcCtD
Tenoxicam—Malnutrition—Capecitabine—kidney cancer	0.000222	0.00105	CcSEcCtD
Tenoxicam—Erythema—Capecitabine—kidney cancer	0.000222	0.00105	CcSEcCtD
Tenoxicam—Oedema—Paclitaxel—kidney cancer	0.000221	0.00104	CcSEcCtD
Tenoxicam—Anaphylactic shock—Paclitaxel—kidney cancer	0.000221	0.00104	CcSEcCtD
Tenoxicam—Dizziness—Sunitinib—kidney cancer	0.000217	0.00103	CcSEcCtD
Tenoxicam—Vomiting—Sorafenib—kidney cancer	0.000217	0.00103	CcSEcCtD
Tenoxicam—Nervous system disorder—Paclitaxel—kidney cancer	0.000217	0.00102	CcSEcCtD
Tenoxicam—Thrombocytopenia—Paclitaxel—kidney cancer	0.000216	0.00102	CcSEcCtD
Tenoxicam—Rash—Sorafenib—kidney cancer	0.000215	0.00102	CcSEcCtD
Tenoxicam—Dermatitis—Sorafenib—kidney cancer	0.000215	0.00102	CcSEcCtD
Tenoxicam—Breast disorder—Doxorubicin—kidney cancer	0.000215	0.00101	CcSEcCtD
Tenoxicam—Skin disorder—Paclitaxel—kidney cancer	0.000215	0.00101	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000214	0.00101	CcSEcCtD
Tenoxicam—Headache—Sorafenib—kidney cancer	0.000214	0.00101	CcSEcCtD
Tenoxicam—Diarrhoea—Dactinomycin—kidney cancer	0.000213	0.00101	CcSEcCtD
Tenoxicam—Anorexia—Paclitaxel—kidney cancer	0.000211	0.000994	CcSEcCtD
Tenoxicam—Gastritis—Doxorubicin—kidney cancer	0.00021	0.000994	CcSEcCtD
Tenoxicam—Vomiting—Sunitinib—kidney cancer	0.000209	0.000987	CcSEcCtD
Tenoxicam—Rash—Sunitinib—kidney cancer	0.000207	0.000979	CcSEcCtD
Tenoxicam—Dermatitis—Sunitinib—kidney cancer	0.000207	0.000978	CcSEcCtD
Tenoxicam—Headache—Sunitinib—kidney cancer	0.000206	0.000973	CcSEcCtD
Tenoxicam—Asthma—Doxorubicin—kidney cancer	0.000205	0.00097	CcSEcCtD
Tenoxicam—Anaemia—Capecitabine—kidney cancer	0.000205	0.000969	CcSEcCtD
Tenoxicam—Hypersensitivity—Vincristine—kidney cancer	0.000205	0.000968	CcSEcCtD
Tenoxicam—Nausea—Sorafenib—kidney cancer	0.000203	0.000958	CcSEcCtD
Tenoxicam—Vertigo—Capecitabine—kidney cancer	0.0002	0.000942	CcSEcCtD
Tenoxicam—Asthenia—Vincristine—kidney cancer	0.0002	0.000942	CcSEcCtD
Tenoxicam—Leukopenia—Capecitabine—kidney cancer	0.000199	0.000939	CcSEcCtD
Tenoxicam—Vomiting—Dactinomycin—kidney cancer	0.000198	0.000935	CcSEcCtD
Tenoxicam—Dyspnoea—Paclitaxel—kidney cancer	0.000197	0.00093	CcSEcCtD
Tenoxicam—Palpitations—Capecitabine—kidney cancer	0.000196	0.000927	CcSEcCtD
Tenoxicam—Rash—Dactinomycin—kidney cancer	0.000196	0.000927	CcSEcCtD
Tenoxicam—Nausea—Sunitinib—kidney cancer	0.000195	0.000922	CcSEcCtD
Tenoxicam—Dyspepsia—Paclitaxel—kidney cancer	0.000194	0.000918	CcSEcCtD
Tenoxicam—Decreased appetite—Paclitaxel—kidney cancer	0.000192	0.000907	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000191	0.000901	CcSEcCtD
Tenoxicam—Fatigue—Paclitaxel—kidney cancer	0.00019	0.000899	CcSEcCtD
Tenoxicam—Diarrhoea—Vincristine—kidney cancer	0.00019	0.000899	CcSEcCtD
Tenoxicam—Asthenia—Gemcitabine—kidney cancer	0.000189	0.000894	CcSEcCtD
Tenoxicam—Constipation—Paclitaxel—kidney cancer	0.000189	0.000892	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000188	0.000887	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000188	0.000886	CcSEcCtD
Tenoxicam—Pruritus—Gemcitabine—kidney cancer	0.000187	0.000881	CcSEcCtD
Tenoxicam—Dry mouth—Capecitabine—kidney cancer	0.000185	0.000873	CcSEcCtD
Tenoxicam—Nausea—Dactinomycin—kidney cancer	0.000185	0.000873	CcSEcCtD
Tenoxicam—Dizziness—Vincristine—kidney cancer	0.000184	0.000868	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000182	0.000858	CcSEcCtD
Tenoxicam—Oedema—Capecitabine—kidney cancer	0.000181	0.000856	CcSEcCtD
Tenoxicam—Diarrhoea—Gemcitabine—kidney cancer	0.000181	0.000852	CcSEcCtD
Tenoxicam—Stomatitis—Doxorubicin—kidney cancer	0.000179	0.000843	CcSEcCtD
Tenoxicam—Nervous system disorder—Capecitabine—kidney cancer	0.000178	0.000839	CcSEcCtD
Tenoxicam—Thrombocytopenia—Capecitabine—kidney cancer	0.000178	0.000838	CcSEcCtD
Tenoxicam—Vomiting—Vincristine—kidney cancer	0.000177	0.000835	CcSEcCtD
Tenoxicam—Skin disorder—Capecitabine—kidney cancer	0.000176	0.000831	CcSEcCtD
Tenoxicam—Urticaria—Paclitaxel—kidney cancer	0.000175	0.000829	CcSEcCtD
Tenoxicam—Rash—Vincristine—kidney cancer	0.000175	0.000828	CcSEcCtD
Tenoxicam—Dermatitis—Vincristine—kidney cancer	0.000175	0.000827	CcSEcCtD
Tenoxicam—Headache—Vincristine—kidney cancer	0.000174	0.000823	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000173	0.000818	CcSEcCtD
Tenoxicam—Anorexia—Capecitabine—kidney cancer	0.000173	0.000816	CcSEcCtD
Tenoxicam—Agranulocytosis—Doxorubicin—kidney cancer	0.000171	0.000807	CcSEcCtD
Tenoxicam—Vomiting—Gemcitabine—kidney cancer	0.000168	0.000792	CcSEcCtD
Tenoxicam—Rash—Gemcitabine—kidney cancer	0.000166	0.000786	CcSEcCtD
Tenoxicam—Dermatitis—Gemcitabine—kidney cancer	0.000166	0.000785	CcSEcCtD
Tenoxicam—Headache—Gemcitabine—kidney cancer	0.000165	0.00078	CcSEcCtD
Tenoxicam—Nausea—Vincristine—kidney cancer	0.000165	0.00078	CcSEcCtD
Tenoxicam—Hepatitis—Doxorubicin—kidney cancer	0.000164	0.000777	CcSEcCtD
Tenoxicam—Hypersensitivity—Paclitaxel—kidney cancer	0.000163	0.000769	CcSEcCtD
Tenoxicam—Urinary tract disorder—Doxorubicin—kidney cancer	0.000162	0.000767	CcSEcCtD
Tenoxicam—Dyspnoea—Capecitabine—kidney cancer	0.000162	0.000763	CcSEcCtD
Tenoxicam—Urethral disorder—Doxorubicin—kidney cancer	0.000161	0.000761	CcSEcCtD
Tenoxicam—Dyspepsia—Capecitabine—kidney cancer	0.00016	0.000754	CcSEcCtD
Tenoxicam—Visual impairment—Doxorubicin—kidney cancer	0.000159	0.000748	CcSEcCtD
Tenoxicam—Asthenia—Paclitaxel—kidney cancer	0.000159	0.000748	CcSEcCtD
Tenoxicam—Decreased appetite—Capecitabine—kidney cancer	0.000158	0.000744	CcSEcCtD
Tenoxicam—Nausea—Gemcitabine—kidney cancer	0.000157	0.00074	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000157	0.000739	CcSEcCtD
Tenoxicam—Fatigue—Capecitabine—kidney cancer	0.000156	0.000738	CcSEcCtD
Tenoxicam—Pruritus—Paclitaxel—kidney cancer	0.000156	0.000738	CcSEcCtD
Tenoxicam—Erythema multiforme—Doxorubicin—kidney cancer	0.000156	0.000734	CcSEcCtD
Tenoxicam—Constipation—Capecitabine—kidney cancer	0.000155	0.000732	CcSEcCtD
Tenoxicam—Eye disorder—Doxorubicin—kidney cancer	0.000154	0.000726	CcSEcCtD
Tenoxicam—Cardiac disorder—Doxorubicin—kidney cancer	0.000153	0.000721	CcSEcCtD
Tenoxicam—Diarrhoea—Paclitaxel—kidney cancer	0.000151	0.000714	CcSEcCtD
Tenoxicam—Angiopathy—Doxorubicin—kidney cancer	0.000149	0.000705	CcSEcCtD
Tenoxicam—Immune system disorder—Doxorubicin—kidney cancer	0.000149	0.000702	CcSEcCtD
Tenoxicam—Dizziness—Paclitaxel—kidney cancer	0.000146	0.00069	CcSEcCtD
Tenoxicam—Mental disorder—Doxorubicin—kidney cancer	0.000144	0.00068	CcSEcCtD
Tenoxicam—Urticaria—Capecitabine—kidney cancer	0.000144	0.00068	CcSEcCtD
Tenoxicam—Malnutrition—Doxorubicin—kidney cancer	0.000143	0.000676	CcSEcCtD
Tenoxicam—Erythema—Doxorubicin—kidney cancer	0.000143	0.000676	CcSEcCtD
Tenoxicam—Vomiting—Paclitaxel—kidney cancer	0.00014	0.000663	CcSEcCtD
Tenoxicam—Rash—Paclitaxel—kidney cancer	0.000139	0.000658	CcSEcCtD
Tenoxicam—Dermatitis—Paclitaxel—kidney cancer	0.000139	0.000657	CcSEcCtD
Tenoxicam—Headache—Paclitaxel—kidney cancer	0.000138	0.000653	CcSEcCtD
Tenoxicam—Hypersensitivity—Capecitabine—kidney cancer	0.000134	0.000631	CcSEcCtD
Tenoxicam—Anaemia—Doxorubicin—kidney cancer	0.000132	0.000625	CcSEcCtD
Tenoxicam—Nausea—Paclitaxel—kidney cancer	0.000131	0.00062	CcSEcCtD
Tenoxicam—Asthenia—Capecitabine—kidney cancer	0.00013	0.000614	CcSEcCtD
Tenoxicam—Vertigo—Doxorubicin—kidney cancer	0.000129	0.000607	CcSEcCtD
Tenoxicam—Pruritus—Capecitabine—kidney cancer	0.000128	0.000606	CcSEcCtD
Tenoxicam—Leukopenia—Doxorubicin—kidney cancer	0.000128	0.000605	CcSEcCtD
Tenoxicam—Palpitations—Doxorubicin—kidney cancer	0.000127	0.000597	CcSEcCtD
Tenoxicam—Diarrhoea—Capecitabine—kidney cancer	0.000124	0.000586	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000121	0.000572	CcSEcCtD
Tenoxicam—Dizziness—Capecitabine—kidney cancer	0.00012	0.000566	CcSEcCtD
Tenoxicam—Dry mouth—Doxorubicin—kidney cancer	0.000119	0.000563	CcSEcCtD
Tenoxicam—Oedema—Doxorubicin—kidney cancer	0.000117	0.000552	CcSEcCtD
Tenoxicam—Anaphylactic shock—Doxorubicin—kidney cancer	0.000117	0.000552	CcSEcCtD
Tenoxicam—Vomiting—Capecitabine—kidney cancer	0.000115	0.000544	CcSEcCtD
Tenoxicam—Nervous system disorder—Doxorubicin—kidney cancer	0.000115	0.000541	CcSEcCtD
Tenoxicam—Thrombocytopenia—Doxorubicin—kidney cancer	0.000114	0.00054	CcSEcCtD
Tenoxicam—Rash—Capecitabine—kidney cancer	0.000114	0.00054	CcSEcCtD
Tenoxicam—Dermatitis—Capecitabine—kidney cancer	0.000114	0.000539	CcSEcCtD
Tenoxicam—Headache—Capecitabine—kidney cancer	0.000114	0.000536	CcSEcCtD
Tenoxicam—Skin disorder—Doxorubicin—kidney cancer	0.000114	0.000536	CcSEcCtD
Tenoxicam—Anorexia—Doxorubicin—kidney cancer	0.000111	0.000526	CcSEcCtD
Tenoxicam—Nausea—Capecitabine—kidney cancer	0.000108	0.000508	CcSEcCtD
Tenoxicam—Dyspnoea—Doxorubicin—kidney cancer	0.000104	0.000492	CcSEcCtD
Tenoxicam—Dyspepsia—Doxorubicin—kidney cancer	0.000103	0.000486	CcSEcCtD
Tenoxicam—Decreased appetite—Doxorubicin—kidney cancer	0.000102	0.00048	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000101	0.000476	CcSEcCtD
Tenoxicam—Fatigue—Doxorubicin—kidney cancer	0.000101	0.000476	CcSEcCtD
Tenoxicam—Constipation—Doxorubicin—kidney cancer	9.99e-05	0.000472	CcSEcCtD
Tenoxicam—PTGS2—C-MYB transcription factor network—GSTM1—kidney cancer	9.93e-05	0.00357	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	9.91e-05	0.00356	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	9.8e-05	0.00353	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	9.8e-05	0.00353	CbGpPWpGaD
Tenoxicam—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	9.79e-05	0.00352	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ATP7B—kidney cancer	9.76e-05	0.00351	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC5A3—kidney cancer	9.76e-05	0.00351	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ANXA2—kidney cancer	9.76e-05	0.00351	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—SOD2—kidney cancer	9.61e-05	0.00346	CbGpPWpGaD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	9.44e-05	0.0034	CbGpPWpGaD
Tenoxicam—PTGS1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.38e-05	0.00338	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	9.37e-05	0.00337	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	9.33e-05	0.00336	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	9.29e-05	0.00334	CbGpPWpGaD
Tenoxicam—Urticaria—Doxorubicin—kidney cancer	9.28e-05	0.000438	CcSEcCtD
Tenoxicam—PTGS2—Spinal Cord Injury—EGR1—kidney cancer	9.17e-05	0.0033	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	9.15e-05	0.00329	CbGpPWpGaD
Tenoxicam—Hypersensitivity—Doxorubicin—kidney cancer	8.61e-05	0.000407	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	8.59e-05	0.00309	CbGpPWpGaD
Tenoxicam—Asthenia—Doxorubicin—kidney cancer	8.38e-05	0.000396	CcSEcCtD
Tenoxicam—Pruritus—Doxorubicin—kidney cancer	8.27e-05	0.00039	CcSEcCtD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	8.16e-05	0.00294	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	8.08e-05	0.00291	CbGpPWpGaD
Tenoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	8.05e-05	0.0029	CbGpPWpGaD
Tenoxicam—Diarrhoea—Doxorubicin—kidney cancer	8e-05	0.000378	CcSEcCtD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—kidney cancer	7.86e-05	0.00283	CbGpPWpGaD
Tenoxicam—Dizziness—Doxorubicin—kidney cancer	7.73e-05	0.000365	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—GSTP1—kidney cancer	7.67e-05	0.00276	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—kidney cancer	7.65e-05	0.00275	CbGpPWpGaD
Tenoxicam—Vomiting—Doxorubicin—kidney cancer	7.43e-05	0.000351	CcSEcCtD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	7.43e-05	0.00267	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—KIT—kidney cancer	7.38e-05	0.00265	CbGpPWpGaD
Tenoxicam—Rash—Doxorubicin—kidney cancer	7.37e-05	0.000348	CcSEcCtD
Tenoxicam—Dermatitis—Doxorubicin—kidney cancer	7.36e-05	0.000348	CcSEcCtD
Tenoxicam—Headache—Doxorubicin—kidney cancer	7.32e-05	0.000346	CcSEcCtD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	7.27e-05	0.00261	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	7.14e-05	0.00257	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—GSTM1—kidney cancer	7.05e-05	0.00254	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—RELA—kidney cancer	6.99e-05	0.00252	CbGpPWpGaD
Tenoxicam—Nausea—Doxorubicin—kidney cancer	6.94e-05	0.000328	CcSEcCtD
Tenoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—kidney cancer	6.8e-05	0.00244	CbGpPWpGaD
Tenoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	6.71e-05	0.00241	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—CYP1A1—kidney cancer	6.69e-05	0.0024	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	6.67e-05	0.0024	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	6.67e-05	0.0024	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.62e-05	0.00238	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	6.57e-05	0.00236	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	6.43e-05	0.00231	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	6.24e-05	0.00224	CbGpPWpGaD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.09e-05	0.00219	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	6.07e-05	0.00218	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	5.99e-05	0.00215	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ACY1—kidney cancer	5.88e-05	0.00212	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTT1—kidney cancer	5.82e-05	0.00209	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	5.64e-05	0.00203	CbGpPWpGaD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	5.62e-05	0.00202	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	5.55e-05	0.002	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	5.48e-05	0.00197	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—PTGS1—kidney cancer	5.45e-05	0.00196	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	5.43e-05	0.00195	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	5.3e-05	0.00191	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	5.3e-05	0.00191	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.15e-05	0.00185	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	5.06e-05	0.00182	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.02e-05	0.0018	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PDHB—kidney cancer	5e-05	0.0018	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—POMC—kidney cancer	4.98e-05	0.00179	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.97e-05	0.00179	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.93e-05	0.00177	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.81e-05	0.00173	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CCBL1—kidney cancer	4.7e-05	0.00169	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ACY1—kidney cancer	4.67e-05	0.00168	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CCBL1—kidney cancer	4.46e-05	0.0016	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.25e-05	0.00153	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PPAT—kidney cancer	4.08e-05	0.00147	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GLIPR1—kidney cancer	4.08e-05	0.00147	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	4.06e-05	0.00146	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	4.04e-05	0.00145	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTP1—kidney cancer	4.03e-05	0.00145	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—AMER1—kidney cancer	4.03e-05	0.00145	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.02e-05	0.00145	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.98e-05	0.00143	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	3.98e-05	0.00143	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PDHB—kidney cancer	3.97e-05	0.00143	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL2—kidney cancer	3.95e-05	0.00142	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.93e-05	0.00141	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	3.86e-05	0.00139	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.82e-05	0.00137	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—FH—kidney cancer	3.79e-05	0.00136	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—APRT—kidney cancer	3.79e-05	0.00136	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	3.75e-05	0.00135	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CCBL1—kidney cancer	3.73e-05	0.00134	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTM1—kidney cancer	3.71e-05	0.00133	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.7e-05	0.00133	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	3.66e-05	0.00132	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GPC3—kidney cancer	3.56e-05	0.00128	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	3.51e-05	0.00126	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	3.47e-05	0.00125	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CA2—kidney cancer	3.47e-05	0.00125	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALAD—kidney cancer	3.38e-05	0.00121	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—GPC3—kidney cancer	3.38e-05	0.00121	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.38e-05	0.00121	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ST3GAL2—kidney cancer	3.3e-05	0.00119	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PPAT—kidney cancer	3.24e-05	0.00116	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GLIPR1—kidney cancer	3.24e-05	0.00116	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALDH1A1—kidney cancer	3.22e-05	0.00116	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.2e-05	0.00115	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	3.18e-05	0.00114	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.16e-05	0.00114	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ST3GAL2—kidney cancer	3.13e-05	0.00112	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MYC—kidney cancer	3.09e-05	0.00111	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ACY1—kidney cancer	3.09e-05	0.00111	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PGK1—kidney cancer	3.09e-05	0.00111	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC5A3—kidney cancer	3.09e-05	0.00111	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—LDHB—kidney cancer	3.03e-05	0.00109	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	3.03e-05	0.00109	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—FH—kidney cancer	3.01e-05	0.00108	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—APRT—kidney cancer	3.01e-05	0.00108	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3e-05	0.00108	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.97e-05	0.00107	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.94e-05	0.00106	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PGK1—kidney cancer	2.93e-05	0.00105	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SLC5A3—kidney cancer	2.93e-05	0.00105	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—LDHB—kidney cancer	2.87e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SFRP2—kidney cancer	2.87e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GPC3—kidney cancer	2.83e-05	0.00102	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CA2—kidney cancer	2.75e-05	0.00099	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.75e-05	0.000989	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALAD—kidney cancer	2.68e-05	0.000964	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TCEB2—kidney cancer	2.68e-05	0.000963	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TCEB1—kidney cancer	2.68e-05	0.000963	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.64e-05	0.000948	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PDHB—kidney cancer	2.63e-05	0.000945	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CA9—kidney cancer	2.63e-05	0.000945	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.62e-05	0.000943	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—POMC—kidney cancer	2.62e-05	0.000943	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ST3GAL2—kidney cancer	2.62e-05	0.000941	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.62e-05	0.000941	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.6e-05	0.000934	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.57e-05	0.000923	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALDH1A1—kidney cancer	2.56e-05	0.00092	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TP53—kidney cancer	2.54e-05	0.000913	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.53e-05	0.00091	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CCBL1—kidney cancer	2.47e-05	0.000889	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC5A3—kidney cancer	2.45e-05	0.000882	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PGK1—kidney cancer	2.45e-05	0.000882	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—LDHB—kidney cancer	2.41e-05	0.000865	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.29e-05	0.000822	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.24e-05	0.000804	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CRABP1—kidney cancer	2.23e-05	0.000803	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	2.22e-05	0.000799	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—RPL14—kidney cancer	2.18e-05	0.000783	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.16e-05	0.000778	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.14e-05	0.000771	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PPAT—kidney cancer	2.14e-05	0.000771	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.12e-05	0.000761	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.1e-05	0.000757	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.09e-05	0.000753	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CA9—kidney cancer	2.09e-05	0.00075	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ITPR2—kidney cancer	2.08e-05	0.000747	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.06e-05	0.00074	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.04e-05	0.000733	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—FH—kidney cancer	1.99e-05	0.000717	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—APRT—kidney cancer	1.99e-05	0.000717	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ITPR2—kidney cancer	1.97e-05	0.000708	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.95e-05	0.0007	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.94e-05	0.000699	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.91e-05	0.000688	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ACHE—kidney cancer	1.89e-05	0.000681	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTT1—kidney cancer	1.89e-05	0.000681	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GPC3—kidney cancer	1.87e-05	0.000674	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CA2—kidney cancer	1.82e-05	0.000655	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SCARB1—kidney cancer	1.79e-05	0.000645	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.79e-05	0.000642	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALAD—kidney cancer	1.78e-05	0.000639	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CRABP1—kidney cancer	1.77e-05	0.000638	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PSMD7—kidney cancer	1.74e-05	0.000626	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.73e-05	0.000623	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.73e-05	0.000621	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.69e-05	0.000609	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—BCHE—kidney cancer	1.65e-05	0.000593	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PSMD7—kidney cancer	1.65e-05	0.000593	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ITPR2—kidney cancer	1.65e-05	0.000593	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC5A5—kidney cancer	1.63e-05	0.000586	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PGK1—kidney cancer	1.62e-05	0.000584	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.62e-05	0.000584	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—LDHB—kidney cancer	1.59e-05	0.000573	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC2A1—kidney cancer	1.57e-05	0.000566	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.53e-05	0.000549	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.52e-05	0.000547	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ACHE—kidney cancer	1.5e-05	0.000541	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTT1—kidney cancer	1.5e-05	0.000541	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SLC2A1—kidney cancer	1.49e-05	0.000536	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—JUNB—kidney cancer	1.48e-05	0.000533	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SCARB1—kidney cancer	1.42e-05	0.000512	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PTGS1—kidney cancer	1.41e-05	0.000507	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PSMD7—kidney cancer	1.38e-05	0.000497	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CA9—kidney cancer	1.38e-05	0.000497	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.35e-05	0.000485	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.33e-05	0.000479	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTP1—kidney cancer	1.31e-05	0.000472	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—BCHE—kidney cancer	1.31e-05	0.000471	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC5A5—kidney cancer	1.29e-05	0.000465	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC2A1—kidney cancer	1.25e-05	0.000449	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ABCB1—kidney cancer	1.24e-05	0.000447	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTM1—kidney cancer	1.21e-05	0.000434	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN2B—kidney cancer	1.21e-05	0.000434	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CRABP1—kidney cancer	1.17e-05	0.000422	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP1A1—kidney cancer	1.14e-05	0.000411	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ITPR2—kidney cancer	1.09e-05	0.000393	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.06e-05	0.00038	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTP1—kidney cancer	1.04e-05	0.000375	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.01e-05	0.000362	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTT1—kidney cancer	9.95e-06	0.000358	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ACHE—kidney cancer	9.95e-06	0.000358	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ABCB1—kidney cancer	9.86e-06	0.000355	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HIF1A—kidney cancer	9.64e-06	0.000347	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TSC2—kidney cancer	9.61e-06	0.000346	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTM1—kidney cancer	9.57e-06	0.000344	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SCARB1—kidney cancer	9.42e-06	0.000339	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.39e-06	0.000338	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTGS1—kidney cancer	9.33e-06	0.000335	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PSMD7—kidney cancer	9.15e-06	0.000329	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP1A1—kidney cancer	9.08e-06	0.000326	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—BCHE—kidney cancer	8.67e-06	0.000312	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC5A5—kidney cancer	8.57e-06	0.000308	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—POMC—kidney cancer	8.52e-06	0.000307	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KIT—kidney cancer	8.49e-06	0.000305	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—APC—kidney cancer	8.49e-06	0.000305	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC2A1—kidney cancer	8.27e-06	0.000298	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.03e-06	0.000289	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—BRAF—kidney cancer	7.98e-06	0.000287	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.46e-06	0.000268	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7e-06	0.000252	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTP1—kidney cancer	6.9e-06	0.000248	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTGS2—kidney cancer	6.8e-06	0.000245	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—POMC—kidney cancer	6.77e-06	0.000243	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—RAF1—kidney cancer	6.66e-06	0.00024	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERBB2—kidney cancer	6.59e-06	0.000237	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ABCB1—kidney cancer	6.53e-06	0.000235	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MTOR—kidney cancer	6.5e-06	0.000234	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD4—kidney cancer	6.49e-06	0.000234	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTM1—kidney cancer	6.34e-06	0.000228	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1B—kidney cancer	6.1e-06	0.00022	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP1A1—kidney cancer	6.01e-06	0.000216	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTEN—kidney cancer	5.93e-06	0.000213	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CTNNB1—kidney cancer	5.77e-06	0.000207	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PTEN—kidney cancer	5.62e-06	0.000202	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.94e-06	0.000178	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAPK3—kidney cancer	4.8e-06	0.000173	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PTEN—kidney cancer	4.71e-06	0.000169	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MYC—kidney cancer	4.67e-06	0.000168	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAPK1—kidney cancer	4.57e-06	0.000164	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—POMC—kidney cancer	4.48e-06	0.000161	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KRAS—kidney cancer	4.32e-06	0.000155	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CA—kidney cancer	4.18e-06	0.00015	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CA—kidney cancer	3.97e-06	0.000143	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTGS2—kidney cancer	3.57e-06	0.000129	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CA—kidney cancer	3.32e-06	0.000119	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTEN—kidney cancer	3.12e-06	0.000112	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.2e-06	7.91e-05	CbGpPWpGaD
